Development of a Virtual Human for Supporting Tobacco Cessation During the COVID-19 Pandemic.
AI
COVID-19
artificial intelligence
chatbot
conversational agent
digital health intervention
eHealth
mobile phone
public health
smoking cessation
tobacco cessation
virtual health worker
virtual human
web-based health
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
05 Dec 2023
05 Dec 2023
Historique:
received:
04
09
2022
accepted:
12
10
2023
revised:
16
02
2023
medline:
7
12
2023
pubmed:
5
12
2023
entrez:
5
12
2023
Statut:
epublish
Résumé
People who consume tobacco are at greater risk of developing severe COVID-19. Unfortunately, the COVID-19 pandemic reduced the accessibility of tobacco cessation services as a result of necessary social restrictions. Innovations were urgently needed to support tobacco cessation during the pandemic. Virtual humans are artificially intelligent computer agents with a realistic, humanlike appearance. Virtual humans could be a scalable and engaging way to deliver tobacco cessation information and support. Florence, a virtual human health worker, was developed in collaboration with the World Health Organization to remotely support people toward tobacco cessation during the COVID-19 pandemic. Florence delivers evidence-based information, assists with making quit plans, and directs people to World Health Organization-recommended cessation services in their country. In this viewpoint, we describe the process of developing Florence. The development was influenced by a formative evaluation of data from 115 early users of Florence from 49 countries. In general, Florence was positively perceived; however, changes were requested to aspects of her design and content. In addition, areas for new content were identified (eg, for nonsmoker support persons). Virtual health workers could expand the reach of evidence-based tobacco cessation information and personalized support. However, as they are a new innovation in tobacco cessation, their efficacy, feasibility, and acceptability in this application needs to be evaluated, including in diverse populations.
Identifiants
pubmed: 38051571
pii: v25i1e42310
doi: 10.2196/42310
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e42310Informations de copyright
©Kate Loveys, Erica Lloyd, Mark Sagar, Elizabeth Broadbent. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.12.2023.